Codes / ICD10CM / A67.3

A67.3 Mixed lesions of pinta

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Mixed lesions of pinta

Summary

Mixed lesions of pinta represent a stage in the chronic skin infection caused by Treponema carateum. These lesions combine features of earlier and later disease phases, including discoloration, scaling, and textural changes. The condition affects exposed areas of the body and progresses through distinct stages, with mixed lesions reflecting a transition between primary and late-stage alterations.

Causes

Mixed lesions of pinta result from infection with Treponema carateum, a spirochete bacterium. Transmission occurs through direct skin-to-skin contact with an infected individual, typically in environments with poor hygiene and limited healthcare access. The bacterium invades the skin, leading to the characteristic mixed presentation of lesions.

Risk Factors

  • Living in or traveling to endemic tropical regions (e.g., parts of Central and South America).
  • Prolonged exposure to infected individuals without protective measures.
  • Limited access to healthcare and hygiene resources.

Symptoms

  • Combined features: Discoloration (hyperpigmentation or hypopigmentation) with scaling or thickening.
  • Textural changes: Atrophy or scarring in affected areas.
  • Progression: Mixed appearance of early and late-stage skin alterations.

Diagnosis

Diagnosis is based on clinical presentation, including the characteristic mixed lesions and history of exposure. Laboratory confirmation may involve dark-field microscopy or serologic testing, though these are less commonly used in resource-limited settings.

Treatment Options

Treatment typically involves antibiotics, such as penicillin, to target the underlying bacterial infection. Topical therapies may address secondary skin changes, and supportive care focuses on managing symptoms and preventing complications.

Prognosis and Follow-Up

With appropriate treatment, the progression of lesions may slow or stabilize. However, late-stage changes like scarring or pigment loss may persist. Follow-up is important to monitor for resolution or complications, especially in endemic areas.

Complications

  • Persistent skin discoloration or scarring.
  • Secondary bacterial infections due to skin breakdown.
  • Social or psychological impact from visible lesions.

Lifestyle & Prevention

  • Avoid direct skin contact with infected individuals in endemic regions.
  • Practice good hygiene and use protective clothing in high-risk areas.
  • Seek early medical care if skin changes occur after potential exposure.

When to Seek Professional Help

Consult a healthcare provider if skin lesions appear, especially after travel to tropical regions, or if existing lesions worsen, spread, or show signs of infection (e.g., increased redness, pus).

Tips for Medical Coders

Document the presence of mixed lesions (combining features of earlier and later stages) and note the clinical context, including exposure history or endemic region. Ensure documentation supports the specific stage of pinta to justify the code A67.3.

Book a walkthrough

A67.3 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.